Neurodegenerative Disease Drug Development
Paul Brennan, President and CEO of NervGen Pharma Corp, developer of treatments related to nerve damage and neurodegenerative diseases, discusses the st...
5328 articles
Paul Brennan, President and CEO of NervGen Pharma Corp, developer of treatments related to nerve damage and neurodegenerative diseases, discusses the st...
Steven Engle, CEO of CohBar, Inc, a clinical stage biotechnology company discusses his article in "Grit Daily" (Jan 8, 2021) on NASA's breakthrough stud...
Mike, a clinical psychologist discusses the podcast he is hosting called "Going There". Learn more on Health Professional Radio.
Tania Gonzalez-Rivera, MD, BENLYSTA Global Medical Affairs Lead at GlaxoSmithKline (GSK) discusses the recent FDA approval of BENLYSTA (Belimumab) the f...
Ed Baker, FACOG, an OB/GYN and Senior Director, Medical Affairs, Cervical Cancer Solutions at Roche Molecular Diagnostics, discusses advanced biomarker ...
Louis Aronne, MD, FACP, Chief Medical Officer of Intellihealth and medical director of the Comprehensive Weight Control Center at Weill Cornell, discuss...
There has been a drastic drop in breast and colorectal cancer screenings. Hospitals that are overrun and overwhelmed have prolonged and, in many cases...
Grant, Ph.D., RN, FAAN, President of the American Nurses Association discusses the COVID-19 HCP vaccine education effort featuring a video series with h...
Katherine Wilemon, founder of the Familial Hypercholesterolemia (FH) Foundation, who had a heart attack at age 39 due to undiagnosed and unmanaged FH, a...
Klaus Witte, Senior Lecturer and Consultant Cardiologist, University of Leeds and Leeds General Infirmary, discusses findings from a new economic study ...